| 2011 |
Human GPN3 stably associates with RNA polymerase II (RNAPII) in both cytoplasmic and nuclear fractions, directly interacts with RNAPII subunit RPB7/RPB4 and the CTD of RNAPII, and depletion of GPN3 by siRNA causes decreased RNAPII levels in the nucleus with cytoplasmic accumulation, establishing GPN3's role in nuclear import of RNAPII. |
Co-immunoprecipitation, siRNA knockdown, subcellular fractionation, dominant-negative GTP-binding pocket mutant stable cell lines |
Molecular and cellular biology |
High |
21768307
|
| 2011 |
Parcs/Gpn3 co-immunoprecipitates with RNA polymerase II, and its knockdown by RNAi causes cytoplasmic retention of Rpb1 (largest RNAPII subunit) and reduction in overall RNA synthesis in MCF-12A cells, demonstrating a critical role for Gpn3 in nuclear accumulation of RNAPII and transcription. |
RNAi knockdown, co-immunoprecipitation, subcellular localization by immunofluorescence, RNA synthesis assay |
Biochimica et biophysica acta |
High |
21782856
|
| 2012 |
In S. cerevisiae, temperature-sensitive alleles of GPN3 cause RNAPII nuclear localization defects and hypersensitivity to transcription inhibition; GPN3 mutants also exhibit RNA polymerase III localization defects. Genetic epistasis shows GPN proteins function upstream of Iwr1 in RNAPII/III biogenesis, as the iwr1Δ nuclear import defect is partially suppressed by NLS-Rpb3 fusion whereas GPN3 mutant defects are not. |
Temperature-sensitive alleles, genetic epistasis, nuclear localization assays, NLS fusion suppression experiments |
Genetics |
High |
23267056
|
| 2014 |
Gpn1 and Gpn3 associate tightly as a complex in mammalian cells: all endogenous Gpn3 co-immunoprecipitates with Gpn1-Flag and vice versa. Gpn1-Gpn3 interaction maintains steady-state protein levels of both GTPases, and the complex undergoes nucleocytoplasmic shuttling revealed by leptomycin B treatment. |
Co-immunoprecipitation, leptomycin B nuclear export inhibition, EYFP/Flag-tagged co-expression localization |
FEBS letters |
High |
25241168
|
| 2017 |
Gpn3 is polyubiquitinated on lysine 216 (but not K189) and degraded by the proteasome specifically in the cell nucleus. Gpn3-Flag undergoes nucleocytoplasmic shuttling, but polyubiquitination and proteasomal degradation occur only in the nucleus. Gpn1 inhibits Gpn3 polyubiquitination in a dose-dependent manner, protecting Gpn3 from degradation. |
Proteasome inhibition (MG132), site-directed mutagenesis (K216R), pulse-chase half-life assay, co-expression with Gpn1-EYFP, subcellular fractionation |
FEBS letters |
High |
29029378
|
| 2017 |
A cancer-associated Q279* nonsense mutation in Gpn3 generates a PDZ-binding motif that causes Gpn3 to enter the nucleus and inhibit Gpn1 nuclear export, resulting in markedly decreased RNAPII nuclear accumulation and transcriptional activity. The dominant effect requires the PDZ-binding motif generated by the Q279* mutation. |
RNAi replacement with RNAi-resistant constructs, subcellular localization, transcriptional activity assay, PDZ-binding motif mutagenesis |
FEBS letters |
Medium |
28940195
|
| 2019 |
FRET analysis and molecular modeling reveal that human Gpn1 and Gpn3 associate through a large heterodimer interface formed by internal α-helix 7, insertion 2, and the GPN-loop from each protein. W132D and M227D mutations in Gpn1 disrupt interaction with Gpn3 by FRET and abolish the dominant-negative effect on RNAPII localization, demonstrating that an intact Gpn1-Gpn3 interaction is required for their cellular function. |
FRET (live cell), molecular modeling based on Npa3 crystal structure, site-directed mutagenesis of interface residues, RNAPII localization assay |
The FEBS journal |
High |
31298811
|
| 2019 |
shRNA-mediated Gpn3 knockdown in breast cancer cell lines causes cytoplasmic retention of a fraction of Rpb1 and markedly decreases cell proliferation across multiple breast cancer subtypes regardless of transformation level, confirming Gpn3 is required for RNAPII nuclear targeting and cell proliferation in breast cancer cells. |
shRNA knockdown, subcellular localization of Rpb1, cell proliferation assay, mammosphere assay |
Technology in cancer research & treatment |
Medium |
31431135
|
| 2020 |
In yeast, rapid degradation of Gpn3 (using auxin-inducible degron system) leads to cytoplasmic accumulation of Rpb1 and defects in RNAPII assembly. Npa3/Gpn1 physically interacts with Gpn3, and there is a mutual dependency of Npa3 and Gpn3 protein levels. Human Gpn1 also physically interacts with Gpn3, paralleling the yeast interaction. |
Auxin-inducible degron (AID) system, co-immunoprecipitation, RNAPII subunit localization assay, multicopy genetic suppressor screening |
FASEB journal |
High |
32985767
|
| 2021 |
GPN1 and GPN3 are upregulated by MYC and direct RNA polymerase I (Pol I) to ribosomal DNA. Constitutively GTP-bound GPN1/3 mutants mitigate the effect of GTP depletion on Pol I localization, demonstrating that GPN1/3 function as GTP-sensing molecules that link nucleotide sufficiency to ribosome biogenesis. |
Coexpression analysis, constitutively GTP-bound mutants, IMPDH inhibition (GTP depletion), Pol I localization to rDNA assay |
The Journal of clinical investigation |
Medium |
33079728
|
| 2022 |
Gpn3 and Npa3 directly participate in assembly of the two largest RNAPII subunits (Rpb1 and Rpb2). When Gpn3 is defective, RNAPII assembly is disrupted and RNAPII subunits accumulate as cytoplasmic foci (termed 'RNAPII assembly stress response'), which is reversible upon recovery of the assembly factor. |
Temperature-sensitive gpn3 mutant alleles, fluorescence microscopy of tagged RNAPII subunits, genetic suppression, reversibility experiments |
International journal of biological macromolecules |
Medium |
35314265
|
| 2022 |
Rtr1 cooperates with Gpn3 and Npa3 to assemble RNAPII; multiple copies of RTR1 suppress cytoplasmic clumping of RNAPII subunits in gpn3-9 mutant. Deletion of RTR1 leads to cytoplasmic clumping of RNAPII subunits, placing Rtr1 in the same assembly pathway as Gpn3. |
Multicopy genetic suppression, RTR1 deletion, fluorescence microscopy of RNAPII subunit localization, catalytically inactive Rtr1 mutant |
FASEB journal |
Medium |
36190433
|
| 2024 |
Gpn3 nucleocytoplasmic shuttling is regulated by CRM1-mediated nuclear export (sensitive to leptomycin B) and by proteasomal degradation. Five NES motifs were identified in Gpn3 primary sequence; inactivation of NES1 or NES3 has the most robust effect on nuclear accumulation. Cells expressing exclusively NES-deficient Gpn3 proliferate slower, indicating nuclear export is important for Gpn3 function. Cell density and serum (growth factors) regulate Gpn3 shuttling: serum stimulation causes rapid but transient nuclear accumulation. |
Leptomycin B treatment, MG132 proteasome inhibition, NES mutagenesis, cell proliferation assay, live-cell fluorescence localization under varying cell density and serum conditions |
Biochimica et biophysica acta. Molecular cell research |
Medium |
38342311
|
| 2025 |
GPN3 interacts with clathrin light chain A (CLTA), AP2B1, and AP2S1. Upregulation of GPN3 inhibits clathrin-coated pit invagination. GPN3 interacts with EGFR and regulates co-localization of EGFR and CLTA as well as EGFR localization in early endosomes upon EGF stimulation, leading to decreased endocytic levels of EGFR and increased EGFR membrane accumulation and prolonged EGFR signaling activation. These effects are dependent on cellular GTP abundance. |
Co-immunoprecipitation (GPN3 with CLTA, AP2B1, AP2S1, EGFR), overexpression and knockdown, EGFR endocytosis assay, clathrin-coated pit assay, co-localization microscopy |
Cell death discovery |
Medium |
39893205
|
| 2026 |
Inactivation of Gpn3 (along with other GPN proteins) results in reversible accumulation of Rpb1, Rpb2, and Rpb3 in cytoplasmic foci (RNAPII Assembly Stress Response, RASR). The molecular chaperone Hsp82 accumulates in and partially co-localizes with these foci. The condensates are protein-based, nucleic acid-free, resist hexanediol dissolution, and show dynamic behavior by FRAP. RASR triggers coordinated transcriptional reprogramming of ribosome biogenesis genes and metabolic pathways. |
GPN protein inactivation, fluorescence microscopy, FRAP, 1,6-hexanediol treatment, RNase/DNase treatment, transcriptomic profiling, Hsp82 co-localization |
International journal of biological macromolecules |
Medium |
41500282
|